scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1053-2498(00)00114-5 |
P698 | PubMed publication ID | 10867335 |
P2093 | author name string | A Cooper | |
N H Brooks | |||
I V Hutchinson | |||
N Yonan | |||
C G Densem | |||
P2860 | cites work | Transforming growth factor beta in tissue fibrosis | Q28239292 |
Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model | Q34133039 | ||
Production of transforming growth factor beta 1 during repair of arterial injury | Q34198234 | ||
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production | Q34339289 | ||
Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions | Q35607475 | ||
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro | Q36223450 | ||
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta | Q36352371 | ||
Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex | Q36755274 | ||
Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. | Q37373677 | ||
Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a "magic bullet". | Q37773499 | ||
TGF-beta and the endothelium during immune injury | Q41469706 | ||
Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures | Q41541840 | ||
Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention | Q41729196 | ||
Transplant coronary artery disease: histopathologic correlations with angiographic morphology | Q43989603 | ||
Early development of accelerated graft coronary artery disease: risk factors and course | Q46315758 | ||
Does cyclosporin promote the secretion of transforming growth factor-beta 1 following pulmonary transplantation? | Q47939699 | ||
Transforming growth factor beta production during rat cytomegalovirus infection | Q57004971 | ||
TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop | Q68482825 | ||
Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells | Q69747770 | ||
Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study | Q71745872 | ||
In vivo hyperexpression of transforming growth factor-beta 1 in humans: stimulation by cyclosporine | Q73277949 | ||
Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival | Q74063049 | ||
Influence of cytokine genotypes on allograft rejection | Q74571356 | ||
Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation | Q77531558 | ||
Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report | Q77664161 | ||
P433 | issue | 6 | |
P304 | page(s) | 551-556 | |
P577 | publication date | 2000-06-01 | |
P1433 | published in | The Journal of Heart and Lung Transplantation | Q2364382 |
P1476 | title | Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation | |
P478 | volume | 19 |
Q80592795 | A novel polymorphism of the gene encoding furin, a TGF-beta1 activator, and the influence on cardiac allograft vasculopathy formation |
Q43614647 | Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis |
Q27011330 | Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis |
Q46706318 | Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African–American renal transplant patients |
Q34810493 | Cytokine gene polymorphism in human disease: on-line databases, supplement 2. |
Q34150345 | Does variability in normal tissue reactions after radiotherapy have a genetic basis--where and how to look for it? |
Q80592801 | Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease |
Q82422603 | Genetic association studies: personalized medicine in cardiac transplantation |
Q36554709 | Genetic predisposition and renal allograft failure: implication of non-HLA genetic variants |
Q80093481 | Heterotopic vascularized murine cardiac transplantation to study graft arteriopathy |
Q74402911 | Interleukin 1 and chronic rejection: possible genetic links in human heart allografts |
Q74618662 | No association between transforming growth factor beta gene polymorphism and acute allograft rejection after cardiac transplantation |
Q64263291 | Non-HLA Genetic Factors and Their Influence on Heart Transplant Outcomes: A Systematic Review |
Q36415330 | Pharmacogenomics and lung transplantation: clinical implications |
Q63880202 | Recipient gene polymorphisms in the Th-1 cytokines IL-2 and IFN-γ in relation to acute rejection and graft vascular disease after clinical heart transplantation |
Q35903927 | Single nucleotide polymorphisms for genes encoding cytokines in the context of cardiac surgery. Part I: Heart transplantation |
Q34405407 | The role of cytokine polymorphisms in rejection after solid organ transplantation |
Q44817953 | Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). |
Q37486196 | Transforming growth factor-beta polymorphisms and cardiac allograft rejection |
Q43721706 | Traumatic arteriogenic erectile dysfunction: a rat model. |
Search more.